Cantor Fitzgerald Maintains Overweight on CVRx, Lowers Price Target to $5
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Cantor Fitzgerald analyst Sarah James maintains CVRx (NASDAQ:CVRX) with a Overweight and lowers the price target from $13 to $5.
Cantor Fitzgerald analyst Sarah James maintains CVRx (NASDAQ:CVRX) with a Overweight and lowers the price target from $13 to $5.